The aims of this study, therefore, are: 1) to expand the complotype with the CFB variant (rs4151667) we found to be highly associated with complement activity; 2) to evaluate the relation of the complotype with complement activation in human plasma samples, representative of the in vivo situation; and 3) to investigate the association between the complotype and AMD. Here, CFB is linked to age-related macular degeneration.